A Contract Research Organisation (CRO), established by ACDIMA to provide principally bioequivalence testing services to the pharmaceutical industry
Founded in 2000 and headquartered in Amman-Jordan, the heart of Middle East
Located in a nicely placed area within the west region of the capital Amman accessible to all visitors.
Provides a tailor-made service to support your challenging regulatory needs with cost-effective prices and in a very short time.
Gained an excellent reputation since its foundation with its multinational presentation.
Considered the largest CRO in the MENA region.
Aligning study timelines to meet your deadlines with a very short project cycle time:
IMP importation & Custom clearance: 1-7 days
IRB review /approval: 1 week
Regulatory approval: 1-4 weeks
Screening: 1-3 days
Study conduct: 1-4 weeks
Bioanalysis: 2-3 weeks
Preliminary results: 1 week
Final report: 1 week